FindMyKOL
Clinical trialNCT07356492RecruitingInterventional

Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Medicine Approach

SponsorVA Office of Research and DevelopmentEnrollment2,700ConnectednessHealthReintegration DifficultiesSuicidal Ideation and Behaviors
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Background Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows that reintegration challenges during this transition are closely linked to increased suicide risk. The Veteran Sponsorship Initiative (VSI) was developed to address this critical period by connecting Transitioning Servicemembers and Veterans (TSMVs) with trained, VA-certified peer sponsors. These sponsors help TSMVs navigate civilian life and access VA care. Early evaluations show that TSMVs matched with sponsors are more likely to report lower levels of reintegration difficulties, higher levels of social support, engage in VA services and report lower rates of depression and suicide risk. This project enhances VSI by integrating predictive analytics-developed in partnership with Harvard Medical School and the DoW STARRS-LS team-to identify high-risk TSMVs before they leave the military. Those identified receive not only a sponsor but also targeted VA mental and health care services. This hybrid effectiveness-implementation study will evaluate the impact of this enhanced model (VSI+) on mental health outcomes and VA engagement among 2,700 high-risk TSMVs. Method/Design The purpose of this PEI proposal is to evaluate VSI expansion into VSI+ with enrollment occurring on four US Army installations (FY2026-2027). The study employs a pragmatic cluster-randomized trial with embedded mixed-method implementation evaluation to compare three arms: 1. Transition as Usual (TAU) 2. VSI Base= peer sponsorship and community support 3. VSI+= VSI Base plus VA stepped care services The evaluation is guided by the RE-AIM framework to assess: * Reach (enrollment rates) * Effectiveness (reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes) * Adoption (site and staff uptake) * Implementation (fidelity and feasibility) * Maintenance (sustainability) Study Aims 1. Effectiveness: Evaluate the impact of VSI Base and VSI+ on reintegration difficulties, depression, anxiety, suicidal ideation/behavior, and VA utilization outcomes. 2. Implementation: Assess the feasibility and fidelity of implementing VSI Base and VSI+ across multiple sites using a bundled strategy. 3. Economic Impact: Estimate the budget impact of VSI Base and VSI+ on healthcare costs, including inpatient, emergency, and outpatient care.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Brigid B Connelly, MA

    Rocky Mountain Regional VA Medical Center, Aurora, CO

    Principal Investigator
  • David E Goodrich, EdD MS MA

    VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

    Principal Investigator
  • Emily R Edwards, PhD

    James J. Peters Veterans Affairs Medical Center

    Principal Investigator
  • Erin P Finley, PhD MPH

    VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    Principal Investigator
  • Jean Yoon, PhD MHS

    VA Palo Alto Health Care System, Palo Alto, CA

    Principal Investigator
  • Joseph C Geraci, PhD

    James J. Peters Veterans Affairs Medical Center

    Principal Investigator
  • Marianne S. Goodman, MD

    James J. Peters Veterans Affairs Medical Center

    Principal Investigator
  • Richard W Seim

    Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • James J. Peters Va Medical Center, Bronx, Ny

    The Bronx, New York, United States

    Emily R Edwards, PhDJoseph C Geraci, PhDMarianne S. Goodman, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jan 2026
Primary completion
30 Sept 2027
Completion
30 Sept 2027
Last update posted
21 Jan 2026
Registered enrollment
2,700
Registry id
NCT07356492

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.